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Introduction: Treatment of chondral injuries remains a major issue despite the many advances made in cartilage
repair techniques. Although it has been postulated that the use of marrow stimulation in combination with
cell-based therapy may provide superior outcome, this has yet to be demonstrated. A pilot study was thus
conducted to determine if bone marrow derived mesenchymal stromal cells (BM-MSCs) have modulatory effects on
the repair outcomes of bone marrow stimulation (BMS) techniques.
Methods: Two full-thickness chondral 5 mm diameter defects were created in tandem on the medial condyle of
left stifle joints of 18 Boer caprine (N = 18). Goats were then divided equally into three groups. Simultaneously,
bone marrow aspirates were taken from the iliac crests from the goats in Group 1 and were sent for BM-MSC
isolation and expansion in vitro. Six weeks later, BMS surgery, which involves subchondral drilling at the defect sites,
was performed. After two weeks, the knees in Group 1 were given autologous intra-articular BM-MSCs (N = 6).
In Group 2, although BMS was performed there were no supplementations provided. In Group 3, no intervention
was administered. The caprines were sacrificed after six months. Repairs were evaluated using macroscopic
assessment through the International Cartilage Repair Society (ICRS) scoring, histologic grading by O’Driscoll score,
biochemical assays for glycosaminoglycans (GAGs) and gene expressions for aggrecan, collagen II and Sox9.
Results: Histological and immunohistochemical analyses demonstrated hyaline-like cartilage regeneration in the
transplanted sites particularly in Group 1. In contrast, tissues in Groups 2 and 3 demonstrated mainly fibrocartilage.
The highest ICRS and O’Driscoll scorings was also observed in Group 1, while the lowest score was seen in Group 3.
Similarly, the total GAG/total protein as well as chondrogenic gene levels were expressed in the same order, that
is highest in Group 1 while the lowest in Group three. Significant differences between these 3 groups were
observed (P <0.05).
Conclusions: This study suggests that supplementing intra-articular injections of BM-MSCs following BMS knee
surgery provides superior cartilage repair outcomes.* Correspondence: tkzrea@um.edu.my
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Table 1 Study design
Group Number Treatment
1 6 Supplement with autologous BM-MSCs
2 6 Single negative (BMS, no supplement)
3 (control) 6 Double negative (no BMS, no supplement)
Nam et al. Arthritis Research & Therapy 2013, 15:R129 Page 2 of 13
http://arthritis-research.com/content/15/5/R129Introduction
Chondral injuries often afflict the young owing to their
athletic lifestyle and the high impact mechanical loading
subjected to their joints during routine activities [1].
Injuries, especially those which result in focal cartilage
defects, lead to an immediate loss in articular surface
smoothness, resulting in the increase in tissue attrition.
This triggers a series of changes to the subchondral bone
which can lead to joint pain and dysfunction which, if left
untreated, can lead to osteoarthritis [2]. Although in rare
cases, it has been reported that the full-thickness chondral
defect can heal spontaneously, the resultant repair tissue
forms fibrous cartilage which will eventually lead to tissue
degeneration [3]. This poses serious issues, as many of
these patients would present with irreversible cartilage
damage by the time they seek help from health care
providers. The urgency to resolve this problem becomes
more apparent when such conditions involve the young
with many years of productivity still expected of them [4,5].
To halt the progress of cartilage deterioration as the
result of focal cartilage damage, several conventional
treatments have been suggested, including marrow
stimulation procedures [6]. This technique involves creating
channels through the subchondral bone that allow access
for blood and marrow elements to reach the damaged
surface, which have been suggested to contain the essential
ingredients by which cartilage healing occurs [7]. However,
the superclot that forms in the defect as it matures with
time tends to develop into a mixture of fibrocartilage
and hyaline-like repair tissue. Nevertheless, using this
technique, Steadman et al. were still able to demonstrate
that bone marrow stimulation (BMS) can produce good
outcomes in short- to mid-term follow-up of patients who
had undergone this procedure [8]. This success, however,
is short-lived and, thus, further improvements to this
technique may lead to better long-term outcomes.
In recent years, it has been suggested that the use of
intra-articular injection of mesenchymal stromal cells
(MSCs) may result in moderately good repair outcomes,
even in joints that have undergone mild degeneration
[9]. In several studies, it has been shown that MSCs in cir-
culating synovial fluid not only restores cartilage integrity
but also halts the progression of cartilage degeneration
[10]. In both BMS and MSC injection to the joint, there
have been many suggestions to the mechanisms involved
that have resulted in the positive outcomes observed;
however, none have been sufficient to provide a satisfactory
or conclusive explanation [11]. It may be the case that the
combination of both techniques may result in a synergistic
outcome, thus providing superior tissue repair. Based on
our extensive literature search, there have not been any
published results that support this notion, although one
study using mononuclear cells and not MSCs suggests
that this may be the case [12]. To prove whether such asynergistic effect exists, a study was conducted using a
focal cartilage defect in a caprine model treated with
BMS with or without intra-articular injection of MSCs.
Outcome measures were conducted six months post-
operative using macroscopic, histology, and selective
cartilage protein and gene expression assessments.
Methods
Animals
Ethical approval for animal research was obtained from
the Institutional Animal Care and Committee (IACUC)
in the Faculty of Veterinary Medicine, University Putra
Malaysia (Ref no: UPM/FPV/PS/3.2.1.551/AUP-R89), and
the Faculty of Medicine, University of Malaya (Ref no:
OS/14/10/2009/NHY (R)). The outcome parameters of 18
adult caprines of the Boer breed (Capra aegragus hircus)
were compared in this study. The average age and weight
of the goats used were 1.5 years (1.2 to 1.8 years) and 33.7
kg (28.8 kg to 38.8 kg), respectively, at the beginning of
the study. Animals were held in big indoor runs for at least
one week in order to acclimatize them to the surroundings,
food was unrestricted and water was available ad libitum
prior to starting the experiment. Animals were randomized
into three groups based on the type of intervention
performed. The groups and interventions performed are
summarized in Table 1. Only the animals from Group 1
underwent bone marrow aspiration from the left iliac crest
region in order to obtain the BM-MSC to be used two
weeks after BMS.
Harvesting and isolation of caprine MSCs
General anesthesia by intravenous ketamine and diazepam
injection were used in this study. Bone marrow was aspi-
rated from the goats using biopsy needles. Bone marrow
aspirates were then placed in syringes containing heparin
(5,000 U) and kept on ice throughout the transportation
to the laboratory. Aspirated bone marrow was added to an
equal volume of pH 7.2 phosphate-buffered saline (PBS)
(Invitrogen-Gibco, Grand Island, NY, USA) and layered on
the density of 1.077 g/mL Ficoll-Paque (Amersham Biosci-
ences, Uppsala, Sweden). Centrifugation at 2,200 rpm for
25 minutes was then performed. The mononuclear
cells were isolated and resuspended with 10 ml low-
glucose Dulbeccoo’s modified eagle medium (L-DMEM)
through centrifugation at 1,600 rpm for 10 minutes. The
supernatant was then discarded, and the cell pellets were
cultured in growth medium (low-glucose DMEM
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penicillin, 100 μg/mL streptomycin and 1% GlutaMAX-1;
Invitrogen-Gibco, USA) in T-75 tissue culture flasks. At three
to four days after culture, fresh growth medium was replaced
every three days until the cultures became 75% to 80% con-
fluent. The cells were serially passaged and expanded up to
passage-2 before being used for transplantation.
In vitro lineage differentiation
The multipotent capacity of caprine MSCs was proven after
in vitro culturing with specific supplements by inducing dif-
ferentiation into osteogenic, chondrogenic and adipogenic
phenotypes with triplicate cultures, respectively. To induce
osteogenic differentiation, confluent passaged-3 cells were
cultured in the osteogenic medium (Invitrogen-Gibco,
USA). After 21 days, Alizarin Red staining was used to ob-
serve the matrix mineralization. For adipogenesis,
adipogenic medium (Invitrogen-Gibco, USA) was used to
induce the differentiation in the confluent culture of
passaged-3 cells. Fourteen days after culture initiation, the
cells were fixed with methanol at room temperature for 10
minutes, rinsed by 60% isopropanol, and stained by using
freshly prepared Oil Red O solution in 99% isopropanol for
15 minutes. Chondrogenic differentiation was induced
using a micromass culture system. For this purpose, 1 ×
106 passaged-3 cells were pelleted under 1,800 rpm for five
minutes and cultured in a chondrogenic medium
(Invitrogen-Gibco, USA). Twenty-eight days after initiation
of the culture, the pellets were removed and subjected to
the following: fixing in 10% formalin for one hour; dehy-
drating in ascending concentrations of ethanol; clearing in
xylene; embedding in paraffin wax and sectioning at 4 μm
using a microtome. The sections were then stained, using
Safranin O for five minutes at room temperature.
Expression of surface markers
To ensure that the isolated cells consist of the homoge-
neous population of the defined MSCpopulation, expres-
sion of surface markers in caprine MSC cultures at
passage-3 was performed using immunohistochemistry
staining. Cells were seeded at 10,000 cells per chamber in
the four-well chamber slides and the protocol was
performed according to the manufacturer’s recommenda-
tion (Dako, Glostrup, Denmark). Briefly, MSCs were fixed
in 4% paraformaldehyde/PBS for 15 minutes, and then
blocked for 30 minutes using hydrogen peroxidase (H2O2)
to prevent endogenous activity. MSCs were then incu-
bated in goat serum working solution for 15 minutes to
block non-specific binding. MSCs were incubated with
primary antibody (rabbit anti-goat CD44+/CD29+ and
CD45-/CD34- monoclonal antibody, 1:100 dilution,
Abcam, Kendall, Sq, Cambridge, UK) at room temperature
for 30 minutes. After washing with PBS, cells were
incubated with secondary antibody (goat anti-rabbit IgG,Dako) at 1:200 dilution for 30 minutes. Cells were then
washed with PBS, stained with 3,3′-diaminobenzidine
tetrahydrochloride (DAB) chromogen substrate and ex-
amined under light microscopy (Nikon Eclipse TE2000-S;
Nikon Corporation, Tokyo, Japan).
Defect localization and surgery
Surgeries were performed under aseptic conditions.
Following the administration of general anesthesia, the
knee joints were surgically approached through medial
parapatellar incisions. The articular surfaces were exposed
by laterally dislocating the patellae. Full-thickness chondral
defects measuring 5 mm diameter (Figure 1B) were created
on the medial condyle of the left knee joint of the caprines
using a custom-made cylindrical chondrotome (Figure 1A).
A similar defect was also created at a site slightly posterior
to the one previously created. Any bone or cartilage debris
was removed carefully either physically or using copious
amounts of normal saline. The wound was closed in layers.
Six weeks after the surgery, the defects were subjected
to BMS using 0.9 mm diameter Kirschner wires, to a
depth of approximately 6 mm to 8 mm (Figure 1C), or
when bleeding was observed from the drill holes. This
technique was similar to that described by Steadman et al.
[7]. The holes were created at the periphery of the defects,
close to the defect walls (to enhance repair tissue integra-
tion) and then advanced to the center, keeping the holes
well-spaced at 1 mm to 2 mm to prevent propagation of
holes and collapse of the subchondral bone (Figure 1D).
Intra-articular injection of caprine MSCs
Two weeks after BMS, the caprines in Group 1, received
a weekly intra-articular injection of autologous MSCs
(1 × 107 cells) for three consecutive weeks. Injections
were performed using large 18G size needles to avoid
lysis of cells.
Macroscopic evaluation
Animals were euthanized at 29 weeks after the initial
stage of cartilage defect creation. The knee joints were
dissected to obtain the distal femur. Gross inspection of the
repaired chondral defects were performed simultaneously.
Two independent examiners who were blinded to the dif-
ferent groups were asked to examine the knee joints. The
joints were photographed, recorded and assessed following
the modified component of the International Cartilage
Repair Society (ICRS) Cartilage Repair Assessment scoring
scale (macroscopic appearance subcategory) [13]. Upon
completion of the scoring, the specimens were halved
using a mechanical bone saw (Fein MultiMasterAccu,
C&E Fein Gmbh, Stuttgart, Germany). The specimens
were then sampled accordingly, in order to perform
several analyses which meant that samples were: a)
fixed in 10% phosphate-buffered formalin for histology
Figure 1 Full thickness chondral defects. (A) Chondral defects with 5 mm diameter chondrotome. (B) Removal of calcified cartilage layer with
curette, leaving an intact subchondral bone plate. (C,D) Five drill holes per chondral defect can be clearly observed after being washed
with saline.
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(GAGs) content and, c) tested using real-time polymerase
chain reaction (RT-PCR) to determine selected gene
expression levels.
Histologic examination and immunohistochemical
staining
The specimens were fixed in 10% buffered formalin
overnight and then decalcified using 10% formic acid.
The specimens were subsequently dehydrated in etha-
nol in a stepwise manner from 70% up to 100%, trans-
ferred to xylene and embedded in paraffin. A total of 4
μm paraffin sections were prepared longitudinally. The
samples were stained with hematoxylin and eosin to
evaluate the cellular architecture, and Safranin O-Fast
Green was used to detect cartilage proteoglycan. Immu-
nohistochemical staining was performed using DAKO
EnVision 1 System peroxidase kit (DAKO, Denmark).
To detect the collagen distribution in the repaired
tissue, the specimen section slides were incubated in
primary antibody solution (Calbiochem-Daiichi Fine
Chemical Co., Takaoka, Toyama, Japan) followed by
secondary antibody and substrate-chromogen solution
following the instructions provided by the manufac-
turer. Histological specimens were scored following thescale provided by the modified O’Driscoll histological
cartilage scoring system [14] (Table 2). Histological
analysis of the repaired tissue was performed for each
specimen by observers who were blinded to the sample
origin. Special attention was made to the overall ap-
pearance of the repaired tissue, cell shape, the extent of
defect filling, and the integration of the newly formed
tissue with the defect edges.
Quantitative analysis of cartilage repair
glycosaminoglycans (GAGs)
Protein and glycosaminoglycan (GAGs) were determined
using a Bio-Rad DC protein assay kit (Bio-Rad Laborator-
ies, Alfred Nobel Drive, Hercules, CA) and Blyscan sul-
fated glycosaminoglycan assay kit (Biocolor Ltd, County
Antrim). The lesions within different groups were pooled
for this analysis. Specimens were dissected and digested
using RIPA buffer (Merck & Co, Whitehouse Station, NJ,
USA) supplemented with protease inhibitors (Sigma-
Aldrich, St Louis, MO) for 30 minutes, following the
manufacturer’s protocol. Spectrophotometer absorbance
measurements were performed at 750 nm and 656 nm for
protein and GAGs assays, respectively. GAGs content was
normalized with the total protein contents (μg GAGs/g
protein).
Table 2 Modified O’Driscoll histological and
histochemical grading scale
Score
Nature of the predominant tissue
Cellular morphology
Hyaline articular cartilage 4
Incompletely differentiated mesenchyme 2
Fibrous tissue or bone 0
Safranin-O staining of the matrix






Smooth and intact 3
Superficial horizontal lamination 2
Fissures - 25 to 100% of the thickness 1
Severe disruption, including fibrillation 0
Structural integrity
Normal 2
Slight disruption, including cysts 1
Severe disintegration 0
Thickness
100% of normal adjacent cartilage 2
50 to 100% of normal cartilage 1
0 to 50% of normal cartilage 0
Bonding to the adjacent cartilage
Bonded at both ends of graft 2
Bonded at one end, or partially at both ends 1
Not bonded 0








<25% of the cells 1
25 to 100% of the cells 0
Freedom from degenerative changes in adjacent cartilage
Normal cellularity, no clusters, normal staining 3
Normal cellularity, mild clusters, moderate staining 2
Mild or moderate hypocellularity, slight staining 1
Severe hypocellularity, poor or no staining 0
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Total RNA was isolated using a homogenizer and then
processed according to the cartilage RNA isolation kit
(Biochain Institute, Breakwater Avenue, Hayward, USA)
protocol. RNA samples were finally re-dissolved in 30 μl
water and stored at -20°C. One μg of RNA was used to gen-
erate cDNA with the Superscript III first strand synthesis
kit (Invitogen-Life Technologies, Carlsbad, CA, USA) fol-
lowing the manufacturers’ instructions. Real-time PCR ana-
lysis (CFX96 Real-time system, Bio-Rad) was performed to
assess the mRNA levels using iQ-SYBR green supermix
(Bio-Rad). The data were normalized using glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). The primers used
for real-time PCR are summarized in Table 3.
Statistical analysis
The overall differences for each parameter were determined
using non-parametric analyses, that is, Kruskal-Wallis and
Mann Whitney U tests, to evaluate the level of significance
between the groups. P-values of less than 0.05 were consid-
ered significant. Statistical analyses were performed using
SPSS version 17 (SPSS Inc, Chicago, IL, USA).
Results
Cell culture
The primary cultures of the goat bone marrow cells
contained mainly fibroblastic cells as well as a few small
round cells. Rounded cells appeared to be reduced in num-
bers in subsequent subcultures. It is likely that only
fibroblastic-appearing MSCs were left at the end of cell cul-
tures (Figure 2).
Characterization of caprine MSCs
Immunophenotyping analysis
The cells showed an abundance of CD29 and moderate
CD44 expressions (Figure 3), which are generally accepted
markers for MSCs [15]. In contrast, no expression of the
hematopoietic lineage markers CD45 and CD 34 was ob-
served in the cultures.
Multi-lineage differentiation
In osteoinductive cultures, nodule-like structures were
observed in certain regions. Using alizarin red staining, red-
mineralizing areas were apparent, indicating that the cells
were in the early stages of bone formation (Figure 4A). In
adipogenic culture, small lipid droplets appeared within the
cytoplasm of the cells on days 3 and 4. They gradually
occupied whole cells by Day 14. The lipid droplets turned
red when stained by the Oil Red O staining (Figure 4B). In
the micro-mass culture system for chondrocyte differenti-
ation, the size of the pellet seemed to be increased during
the culture period, probably as a result of matrix produc-
tion and secretion. The metachromatic nature of the matrix
was demonstrated by the Safranin O staining (Figure 4C).
Table 3 RT-PCR primers sequences (1st BASE Pte. Ltd., Singapore)
Gene RT-PCR primer sequences Tm (°C) GC (%)
Collagen II (Forward) 5′-CTG GAT GCC ATG AAG GTT TT-3′ 58.4 45.0
Collagen II (Reverse) 5′-TCT TGT CCT TGC TCT TGC TG-3′ 60.4 50.0
Aggrecan (Forward) 5′-GCA AGT GGT CTT CCT TCT GG-3′ 62.4 55.0
Aggrecan (Reverse) 5′-TTC CAC CAA TGT CGT ATC CA-3′ 58.4 45.0
Sox 9 (Forward) 5′-TGA AGA AGG AGA GCG AGG AG-3′ 62.4 55.0
Sox 9 (Reverse) 5′-GAC GTG CGG CTT GTT CTT-3′ 59.9 55.6
GAPDH (Forward) 5′-GCT CTC TTC CAG CCT TCC TT-3′ 62.4 55.0
GAPDH (Reverse) 5′-TAG AGG TCC TTG CGG ATG TC-3′ 62.4 55.0
GC (%), GC content; Tm (°C), Melting temperature.
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to undergo tri-lineage differentiations, including chondro-
genic, osteogenic and adipogenic differentiation [16].
Macroscopic observations
No signs of osteoarthrosis, such as osteophytes, cyst forma-
tion, cartilage erosion or synovial proliferation, were
observed in any of the knees. At 29 weeks, the typical
macroscopic appearance of the MSC-treated specimens,
that is, Group 1, indicated marked improvement of the fill-
ing of the defects as compared with the other groups
(figures not provided). In this group, healing was almost
complete and the reparative tissue produced appeared simi-
lar to normal cartilage. There also appeared to be goodFigure 2 Caprine bone marrow cell culture. At primary culture passage-
The number of clear cells was decreased during the passages and fibroblasintegration of tissue at the margins of the repair site, with
flush and smooth surfaces, and good thickness observed on
the repaired cartilage. Partial filling of the defect was seen in
the BMS group, that is, Group 2, with clear apparent edges
and irregular surfaces. No healing was seen in the control
group and, the margins of the defects were clearly dis-
tinguishable with minimal filling of the reparative tissue.
These macroscopic observations were scored using the
ICRS visual scoring system (Figure 5). Overall, the MSC-
treated group had the most consistently good cartilage
repair, whereas the untreated group had the worst overall
repair. Significant differences were observed between the
MSC-treated group (mean score = 9.20 ± 1.16) and the
BMS group (mean score = 5.67 ± 0.52; P <0.05) for ICRS0 (Day 6), fibroblastic as well as small clear cells can be observed.
tic cells became dominant in culture.
Figure 3 Immunophenotyping of caprine MSCs for expression of multiple CD antigens. (A) CD 29, (B) CD 44, (C) CD 45,
and (D) CD 34.
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(C) Chondrogenic differentiation.
Figure 5 Macroscopic ICRS scoring of chondral defect repair. (Significance is represented by *).
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the control group which has a mean score of 3.00 ± 0.89
(P <0.05).Histological observations
The microscopic appearance of the tissue using various
staining methods revealed cartilage regeneration within
the treated sites. There was marked improvement in the
quality of the repaired tissue in the MSC-treated group
when compared to the other groups (Figure 6). The tissue
was hyaline-like, with good integration, thickness and sur-
face regularity. In contrast, the untreated defects did not
appear to undergo complete healing. In the hematoxylin
and eosin-stained sections, the MSC-treated group showed
substantial thickening of the cartilage tissue when com-
pared with the other groups. Most of the chondrocytes of
this group had an appearance comparable with that
of hyaline cartilage. At higher magnification, the cells
resembled well-differentiated chondrocytes which were
surrounded by metachromatic matrix (Figure 6). The
regenerated tissues from MSC-treated groups showed
a continuous surface with a mixture of hyaline and
fibrocartilage. Furthermore, the MSC-treated tissue
sections showed relatively heavier staining with Safranin
O, suggesting a higher concentration of proteoglycans,
which is one of the major components of cartilage tissue.
Immunohistochemical staining for type II collagen further
confirmed that MSC-treated tissue sections showed a
relatively higher expression of cartilaginous collagen
throughout the whole neocartilage as compared with
other treated groups. This distribution pattern is similar
to that of the normal cartilage.
O’Driscoll histological scores (Figure 7) of the post-
implantation repair tissue was significantly (P <0.05)higher in the transplanted sites of the MSC treated group
(19.50 ± 1.52), than that for the group BMS (13.67 ± 1.86)
and the control group (5.67 ± 1.0333).
Biochemical analysis
Consistent with the morphological and histological scores,
the mean levels of GAG/protein (μg/mg) were higher
in the MSC-treated knees (8.24 ± 0.94) than the BMS
(4.25 ± 0.42) and the defect groups (2.65 ± 0.22) (Figure 8).
A significant difference in GAGs/protein content was
observed between all groups when compared with normal
caprine cartilage.
Gene expression analysis
Comparative analysis of cartilage gene expressions for all
the groups is shown in Figure 9. Significant differences
were observed among all groups in aggrecan and SOX-9
(P <0.05). Although significant differences were observed
in the expression of type II collagen between the Groups 1
or 2 vs. Group 3, no significant difference was observed
between the treated groups, that is, Groups 1 and 2.
Discussion
In the present study, the potential of autologous BM-MSCs
was compared to a standard treatment for focal cartilage
defect, that is, subchondral drilling as the method for
marrow stimulation, in caprine models. Data from the
present study suggest that the use of BM-MSCs as an
adjunct therapy provides certain levels of improvements
to this method of cartilage repair.
Although the authors of the present paper are only
aware that the present study conducted is the first to
demonstrate such findings, there were several previous
studies using almost similar techniques that are worth
Figure 7 Quantitative histologic evaluation of the regenerated cartilage using O’Driscoll scores. (Significance is represented by *).
Figure 6 Histological images at the 29th week. a. (A) Normal knee, (B) Chondral defect, (C) Defects treated with BMS, (D) Defect treated with
autologous MSCs. (defect region s represented by ▼). b. Different images of histological staining (Saf-O and H&E) from the edge to the central
lesion (1 to 5).
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Figure 8 Comparison in the glycosaminoglycan/protein content in the pooled lesions within the different groups.
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of bone marrow aspirates and hyaluronic acid (HA)
in improving the repair of BMS-treated chondral de-
fects. In their experimental study, they found that
from using this technique the cartilage repair pro-
duced integrated hyaline-like tissue. This led to their
claim that there may be a redundancy of practicing
MSCs’ isolation and in vitro expansion, as marrow as-
pirates may be sufficient to achieve good results.
However, it is noteworthy that the limitations in this
study were obvious. Among these was the fact that
the conclusion was based on a single histological
score using four goats in each group. It was statisti-
cally weak and lacked sufficient measured parameters.
The authors then published a cohort study involving
50 patients but this time using peripheral derived stemFigure 9 Gene expression analyses of aggrecan, collagen II and SOX9cells [17]. They claim that the outcome was good, based
on limited representative histological scoring and MRI
only. However, there are several issues that this paper
did not address, and this could have led to the over-
rated findings of that reported study. While the authors
mentioned that the cells obtained from the peripheral
blood were stem cells, there was no evidence to support
such claims since there was no cellular characterization
performed. Furthermore, the cells obtained do not ful-
fill any criteria that identify them as stem cells, that is,
the ability for higher cell potency, such as multipotency.
With no cell sorting or selection performed, at best
the cells used can be described as mixed mononuclear
cells. There also appears to be a discrepancy between
the histological and patient outcome scores which
does not appear to correlate, demonstrating thatdemonstrates variations between groups.
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been concluded. The issue in this study, and that of
others, would have been whether histological scores
reflect the good outcomes that are measured following
any tissue repair. In many of the studies we reviewed, al-
though histological analyses were used, other parameters
were also measured which include patient scores, protein
and/or gene expression, and functional biomechanical
analyses [18,19]. In these studies, correlations between
histological scores and the final outcomes were always
present. This is similar to what was found in our study.
There was strong correlation found between these scores
and that each of the measured parameter appears to
corroborate the findings of the other parameters. We
can, therefore, safely assume that the reports from our
study are more likely to reflect better accuracy and thus
are more reliable as compared to the study reporting the
use of marrow or peripheral blood mononuclear cells.
In a separate study by Lee et al., chondral defects
treated using bone marrow MSCs only, contributed to
superior cartilage repair [20]. This seems to support our
findings that when a combination of MSCs and BMS is
used, a superior outcome can be expected. Unlike the
previous study by Saw et al., which lacked characterization
to claim that the cells were stem cells, the study by Lee
et al. demonstrated several features which suggest that
the cells used were as such, albeit limited in terms of
today’s standard since no surface CD marker expressions
were investigated in their study. One advantage their study
offered over the presently reported article is that obser-
vations were carried out in two different time points,
which showed progressive improvements. In contrast,
ours, which lasted up to 29 weeks, merely showed good
repair outcomes in the treated group. One may argue that
given a larger time scale, those goats not supplemented
may have had comparable outcomes. Nevertheless, if no
improvements were observed at six months, we can safely
say that a treatment has most likely reached its ultimate
endpoint of progression.
There were several studies that used intra-articular
injection of stem cells; however, these involved smaller
animals without marrow stimulations and are usually
osteoarthritic models as opposed to focal cartilage defects.
It is worth noting that osteoarthritis represents a degen-
erative stage which is usually the end stage of a diseased
condition, while focal cartilage defects represent the
pre-degenerative state at best. Among the studies worth
mentioning is that by Agung et al. [21], which evaluated
the use of MSCs in rodents. It was demonstrated that
using MSCs injected into injured knee joints could
mobilize these cells to the injured area, contributing
to tissue regeneration. Similarly, this was observed
by our co-researchers [10]. They examined the effects of
MSCs, HA and the combination of HA-MSCs in treatingosteoarthritis (OA) in a rat model. Their study suggested
that the use of either HA or MSCs effectively reduces OA
progression better than their combined use, which
suggests that MSCs have modulatory effects on damaged
articular cartilage. These studies appear to suggest
that the findings of our study are not unexpected as
MSCs produce positive healing effects when injected
intra-articularly.
The reason for the fibrous tissue formation instead of
hyaline cartilage seen in the BMS only group may be
explained by the inflammatory response invoked due to
trauma. It is suggested that the combination of BMS and
BM-MSC may have slowed this process, thereby promoting
hyaline cartilage regeneration as opposed to fibrocartilage
formation. The reason for this, and even for those observed
in our study, is rather contentious, since there are already
many scientists debating the issue as to whether the
improvement seen in such cases is the direct result of
the repair by the MSCs, or whether it is the factors
produced by MSCs, or even perhaps the proteins they
attract which ultimately result in direct repair or retardation
of the inflammatory process [11]. In previous reports,
MSCs are said to be able to secrete a broad spectrum
of bioactive molecules that have immunoregulatory [22-24]
and/or regenerative activities [25]. Bioactive factors secreted
by MSCs have been shown to inhibit tissue scarring;
suppress apoptosis, inflammatory and fibrotic; stimulate
angiogenesis where MSCs secrete a growth factor, VEGF
(Vascular Endothelium Growth Factor), which stimulates
vascularization; and enhance mitosis of tissue-intrinsic
stem or progenitor cells. Other studies have shown that
MSCs attach to the defect sites while others have shown
that in the transplanted site MSCs regress dramatically to
a point that they are no longer viable [26,27]. Regardless
of the mechanisms involved, the present study clearly
demonstrated a correlation between the use of MSCs with
superior tissue repair, which will require further investiga-
tions if we wish to elicit the mechanisms involved. It must
be stressed that the data presented here were not only
based on macroscopic and histological assessments, but
also include other investigations, such as GAG content
and selective cartilage gene expression, that is, SOX9 and
Collagen II, which demonstrated a significant repair
process as compared to BMS alone. This demonstrates the
complex relationship in the healing processes involved,
which justifies our claims that the use of MSCs as an
intra-articular adjuvant to BMS improves the many facets
of articular joint healing and that the observation made is
not merely by chance.
Despite the robust findings presented here, our study
presents several limitations that are worth noting. Financial
restriction prohibited functional assessment of the repaired
site, such as biomechanical testing, to be conducted. Thus,
it was difficult to ensure whether our observation of the
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proportional to the biomechanical function of the tissues.
Nevertheless, we consider that this study still provides
valuable findings since the conclusions were drawn using
well-accepted experimental techniques utilized in several
other previous studies [28,29]. Introduction of another
treatment arm that utilizes a standard treatment approach
for cartilage repair, such as hyaluronic acid [30] injection,
although not mandatory, could have led to a more
comprehensive conclusion. Improvement could also be
made to the study by using a larger number of animals,
thereby increasing the significance levels in this study.
Nevertheless, one could argue that statistically this
number of samples was deemed appropriate as is. It is
well known that repair of articular cartilage lesions
remodels with time [6,31-33]. Evaluation of the result
at only one time point, at six months, is hence unable
to detect progressive remodeling that has been shown
to occur beyond a year [6]. This should be addressed in
future studies.Conclusions
In conclusion, our preliminary study demonstrates that
within reasonable limits, the use of supplementary intra-
articular injection of BM-MSCs produced modulatory
effects on the repair produced by marrow stimulation.
This study, however, will require further evaluations and
more convincing results using more rigorous experiments.
These questions will be answered in our ongoing study,
which is presently being conducted based on the results of
the currently reported pilot project.
Abbreviations
BM-MSCs: Bone marrow derived mesenchymal stromal cells; BMS: Bone
marrow stimulation; CD: Cluster of differentiation; cDNA: Complementary
deoxyribonucleic acid; Col-II: Collagen type II; DAB: 3,3′-Diaminobenzidine;
g: gram; GAGs: Glycosaminoglycans; GAPDH: Glyceraldehyde-3-phosphate
dehydrogenase; H&E: Hematoxylin and eosin; H2O2: Hydrogen peroxide;
HA: Hyaluronic acid; IACUC: Institutional animal care and committee;
ICRS: International cartilage repair society; kg: Kilogram; L-DMEM:
Low-glucose Dulbecco’s modified eagle medium; mg: Milligram;
min: Minute; ml: Milliliter; mm: Millimetre; MSCs: Mesenchymal stromal cells;
nm: Nanometre; OA: Osteoarthritis; PBS: Phosphate-buffered saline;
RIPA: Radio-immunoprecipitation assay; RNA: Ribonucleic acid;
rpm: Revolution per minute; RT-PCR: Real-time polymerase chain reaction;
Saf-O: Safranin O; Tm: Melting temperature; μg: Microgram; VEGF: Vascular
endothelium growth factor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TK, NHY, PK, LC and WLCP conceived and designed the study. NHY and PK
performed cell cultures, histological, biochemical and immunohistochemical
analyses. NHY, PK and SVN carried out the gene expression analyses. TK and
LC performed scoring systems and image analyses. WLCP and PH performed
the surgery and the administration of cells into the caprine knee joint, while
CHC performed the anesthesia procedures. TK, NHY, PK and SVN helped to
draft the manuscript. All authors read and approved the final manuscript.Acknowledgements
The authors would like to thank Dr Haryanti Azura bt Hj Mohd Wali, Lim Hui
Xuan, Murugarajah a/l Narayan and Cheryl Chua Shwu-Yng for assistance
with animal work. This research is funded by the University of Malaya HIR-
MOHE Research Grant and UM Research Grant RG153/09HTM.
Author details
1Tissue Engineering Group, NOCERAL, Department of Orthopaedic Surgery,
Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
2Faculty of Veterinary Medicine, University Putra Malaysia, 43400 Serdang,
Selangor, Malaysia. 3Department of Orthopaedic, Faculty of Medicine and
Health Sciences, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia.
4Department of Anaesthesiology, Faculty of Medicine, University of Malaya,
50603 Kuala Lumpur, Malaysia.
Received: 7 May 2013 Accepted: 30 August 2013
Published: 20 September 2013References
1. Flanigan DC, Harris JD, Trinh TQ, Siston RA, Brophy RH: Prevalence of
chondral defects in athletes’ knees: a systematic review. Med Sci Sports
Exerc 2010, 42:1795–1801.
2. Messner K, Gillquist J: Cartilage repair. A critical review. Acta Orthop Scand
1996, 67:523–529.
3. Mierisch CM, Wilson HA, Turner MA, Milbrandt TA, Berthoux L,
Hammarskjöld ML, Rekosh D, Balian G, Diduch DR: Chondrocyte
transplantation into articular cartilage defects with use of calcium
alginate: the fate of the cells. J Bone Joint Surg Am 2003, 85-A:1757–1767.
4. Buckwalter JA, Mankin HJ: Articular cartilage repair and transplantation.
Arthritis Rheum 1998, 41:1331–1342.
5. Hunziker EB: Articular cartilage repair: are the intrinsic biological
constraints undermining this process insuperable? Osteoarthritis Cartilage
1999, 7:15–28.
6. Strauss E, Schachter A, Frenkel S, Rosen J: The efficacy of intra-articular
hyaluronan injection after the microfracture technique for the treatment
of articular cartilage lesions. Am J Sport Med 2009, 37:720–726.
7. Steadman JR, Miller BS, Karas SG, Schlegel TF, Briggs KK, Hawkins RJ: The
microfracture technique in the treatment of full-thickness chondral
lesions of the knee in National Football League players. J Knee Surg 2003,
16:83–86.
8. Steadman JR, Briggs KK, Rodrigo JJ, Kocher MS, Gill TJ, Rodkey WG:
Outcomes of microfracture for traumatic chondral defects of the knee:
average 11-year follow-up. Arthroscopy 2003, 19:477–484.
9. Weissman IL: Translating stem and progenitor cell biology to the clinic:
barriers and opportunities. Science 2000, 287:1442–1446.
10. Suhaeb AM, Naveen S, Mansor A, Kamarul T: Hyaluronic acid with or
without bone marrow derived-mesenchymal stem cells improves
osteoarthritic knee changes in rat model: a preliminary report. Indian J
Exp Biol 2012, 50:383–390.
11. McIlwraith CW, Frisbie DD, Rodkey WG, Kisiday JD, Werpy NM, Kawcak CE,
Steadman JR: Evaluation of intra-articular mesenchymal stem cells to
augment healing of microfractured chondral defects. Arthroscopy 2011,
27:1552–1561.
12. Saw KY, Hussin P, Loke SC, Azam M, Chen HC, Tay YG, Low S, Wallin KL,
Ragavanaidu K: Articular cartilage regeneration with autologous marrow
aspirate and hyaluronic acid: an experimental study in a goat model.
Arthroscopy 2009, 25:1391–1400.
13. Brittberg M, Nilsson A, Lindahl A, Ohlsson C, Peterson L: Rabbit articular
cartilage defects treated with autologous cultured chondrocytes. Clin
Orthop Relat Res 1996, 326:270–283.
14. O’Driscoll SW, Marx RG, Beaton DE, Miura Y, Gallay SH, Fitzsimmons JS:
Validation of a simple histological-histochemical cartilage scoring
system. Tissue Eng 2001, 7:313–320.
15. Boo L, Selvaratnam L, Tai CC, Ahmad TS, Kamarul T: Expansion and
preservation of multipotentiality of rabbit bone-marrow derived
mesenchymal stem cells in dextran-based microcarrier spin culture.
J Mater Sci Mater Med 2011, 22:1343–1356.
16. Tan SL, Ahmad TS, Selvaratnam L, Kamarul T: Isolation, characterization
and the multi-lineage differentiation potential of rabbit bone
marrow-derived mesenchymal stem cells. J Anat 2013, 222:437–450.
Nam et al. Arthritis Research & Therapy 2013, 15:R129 Page 13 of 13
http://arthritis-research.com/content/15/5/R12917. Saw KY, Anz A, Siew-Yoke Jee C, Merican S, Ching-Soong Ng R, Roohi SA,
Ragavanaidu K: Articular cartilage regeneration with autologous
peripheral blood stem cells versus hyaluronic acid: a randomized
controlled trial. Arthroscopy 2013, 29:684–694.
18. Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH: Autologous bone
marrow-derived mesenchymal stem cells versus autologous chondrocyte
implantation: an observational cohort study. Am J Sports Med 2010,
38:1110–1116.
19. Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E, Lindahl A:
Two- to 9-year outcome after autologous chondrocyte transplantation of
the knee. Clin Orthop Relat Res 2000, 374:212–234.
20. Lee KB, Hui JH, Song IC, Ardany L, Lee EH: Injectable mesenchymal stem
cell therapy for large cartilage defects - a porcine model. Stem Cells 2007,
25:2964–2971.
21. Agung M, Ochi M, Yanada S, Adachi N, Izuta Y, Yamasaki T, Toda K:
Mobilization of bone marrow-derived mesenchymal stem cells into the
injured tissues after intraarticular injection and their contribution to
tissue regeneration. Knee Surg Sports Traumatol Arthrosc 2006,
14:1307–1314.
22. Chen X, Armstrong MA, Li G: Mesenchymal stem cells in
immunoregulation. Immunol Cell Biol 2006, 84:413–421.
23. Uccelli A, Pistoia V, Moretta L: Mesenchymal stem cells: a new strategy for
immunosuppression? Trends Immunol 2007, 28:219–226.
24. Shi Y, Hu G, Su J, Li W, Chen Q, Shou P, Xu C, Chen X, Huang Y, Zhu Z,
Huang X, Han X, Xie N, Ren G: Mesenchymal stem cells: a new strategy
for immunosuppression and tissue repair. Cell Res 2010, 20:510–518.
25. Dashtdar H, Rothan HA, Tay T, Ahmad RE, Ali R, Tay LX, Chong PP, Kamarul
T: A preliminary study comparing the use of allogenic chondrogenic
pre-differentiated and undifferentiated mesenchymal stem cells for the
repair of full thickness articular cartilage defects in rabbits. J Orthopaed
Res 2011, 29:1336–1342.
26. Kamarul T, Selvaratnam L, Masjuddin T, Ab-Rahim S, Ng C, Chan KY, Ahmad
TS: Autologous chondrocyte transplantation in the repair of full-
thickness focal cartilage damage in rabbits. J Orthop Surg (Hong Kong)
2008, 16:230–236.
27. Kamarul T, Ab-Rahim S, Tumin M, Selvaratnam L, Ahmad TS: A preliminary
study of the effects of glucosamine sulphate and chondroitin sulphate
on surgically treated and untreated focal cartilage damage. Eur Cell Mater
2011, 21:259–271. discussion 270–271.
28. Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M, Koyama T, Nawata M,
Tensho K, Kato H, Uematsu K, Kuroda R, Kurosaka M, Yoshiya S, Hattori K,
Ohgushi H: Safety of autologous bone marrow-derived mesenchymal
stem cell transplantation for cartilage repair in 41 patients with 45 joints
followed for up to 11 years and 5 months. J Tissue Eng Regen Med 2011,
5:146–150.
29. Harris JD, Brophy RH, Siston RA, Flanigan DC: Treatment of chondral
defects in the athlete’s knee. Arthroscopy 2010, 26:841–852.
30. Maniwa S, Ochi M, Motomura T, Nishikori T, Chen J, Naora H: Effects of
hyaluronic acid and basic fibroblast growth factor on motility of
chondrocytes and synovial cells in culture. Acta Orthop Scand 2001,
72:299–303.
31. Kogan G, Soltes L, Stern R, Gemeiner P: Hyaluronic acid: a natural
biopolymer with a broad range of biomedical and industrial
applications. Biotechnol Lett 2007, 29:17–25.
32. Forsey RW, Fisher J, Thompson J, Stone MH, Bell C, Ingham E: The effect of
hyaluronic acid and phospholipid based lubricants on friction within a
human cartilage damage model. Biomaterials 2006, 27:4581–4590.
33. Goldberg VM, Buckwalter JA: Hyaluronans in the treatment of
osteoarthritis of the knee: evidence for disease-modifying activity.
Osteoarthritis Cartilage 2005, 13:216–224.
doi:10.1186/ar4309
Cite this article as: Nam et al.: The effects of staged intra-articular
injection of cultured autologous mesenchymal stromal cells on the
repair of damaged cartilage: a pilot study in caprine model. Arthritis
Research & Therapy 2013 15:R129.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
